X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Photo by Shutterstock

The explosive growth of the global life sciences sector and the real property needs it entails have captured the attention of commercial real estate investors of all stripes. According to CBRE’s US Real Estate Market Outlook 2020, from 2014-2019, life sciences real estate (inclusive of medical office), accounted for an annual average investment of $18.7 billion—an astounding figure. Now, the tragic outbreak of COVID-19 has transformed this burgeoning real estate asset class from one of excitement, to one of existential importance.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 3 free articles* across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.